The Enterprise Value as of September 2024 (TTM) for IntelGenx Technologies Corp. (IGXT) is 45.38M

According to IntelGenx Technologies Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 45.38M. This represents a change of 7.86% compared to the average of 42.07M of the last 4 quarters.

IntelGenx Technologies Corp. (IGXT) Historical Enterprise Value (quarterly & annually)

How has IGXT Enterprise Value performed in the past?

The mean historical Enterprise Value of IntelGenx Technologies Corp. over the last ten years is 43.27M. The current 45.38M Enterprise Value has changed 10.39% with respect to the historical average. Over the past ten years (40 quarters), IGXT's Enterprise Value was at its highest in in the September 2018 quarter at 92.89M. The Enterprise Value was at its lowest in in the March 2020 quarter at 22.68M.

IntelGenx Technologies Corp. (IGXT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of IntelGenx Technologies Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IntelGenx Technologies Corp. (IGXT) Average Enterprise Value

How has IGXT Enterprise Value performed in the past?

The current Enterprise Value of IntelGenx Technologies Corp. (IGXT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

IntelGenx Technologies Corp. (IGXT) Enterprise Value vs. Peers

How is IGXT’s Enterprise Value compared to its peers?

IntelGenx Technologies Corp.’s Enterprise Value is less than Adynxx, Inc. (0), greater than NLS Pharmaceutics AG (87.12K), greater than Ascletis Pharma Inc. (7.12M), less than Sirona Biochem Corp. (734.10M), greater than LianBio (18.20M), less than Fennec Pharmaceuticals Inc. (0), greater than Larimar Therapeutics, Inc. (-66141903.00), less than Verrica Pharmaceuticals Inc. (129.55M), less than Homology Medicines, Inc. (410.36M), less than Candel Therapeutics, Inc. (93.32M), greater than PMV Pharmaceuticals, Inc. (-103303255.00), less than Acurx Pharmaceuticals, Inc. (245.92M), greater than Monopar Therapeutics Inc. (41.44M), greater than Enochian Biosciences, Inc. (25.64M), greater than Connect Biopharma Holdings Limited (7.75M), less than Acumen Pharmaceuticals, Inc. (88.02M), greater than Eton Pharmaceuticals, Inc. (-40618512.00), less than Nuvation Bio Inc. (106.85M), less than Eledon Pharmaceuticals, Inc. (139.87M), less than null (975.25M), less than null (73.76M),

Build a custom stock screener for IntelGenx Technologies Corp. (IGXT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IntelGenx Technologies Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IntelGenx Technologies Corp. (IGXT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IntelGenx Technologies Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.